Skip to main content
Thomas Batchelor, MD, Internal Medicine, Huntersville, NC

ThomasABatchelorMD

Internal Medicine Huntersville, NC

Medical Director

Dr. Batchelor is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Batchelor's full profile

Already have an account?

  • Office

    16455 Statesville Rd
    Suite 360
    Huntersville, NC 28078
    Phone+1 704-801-3300
    Fax+1 704-896-0599

Summary

  • Dr. Thomas Batchelor is an internist in Huntersville, NC and is affiliated with multiple Atrium Health hospitals in the area. He received his medical degree from the University of Virginia School of Medicine. He completed residency and chief residency at Emory University. He has been in practice for 27 years.

Education & Training

  • Emory University School of Medicine
    Emory University School of MedicineChief Residency, Internal Medicine, 1997 - 1998
  • Emory University School of Medicine
    Emory University School of MedicineResidency, Internal Medicine, 1994 - 1997
  • University of Virginia School of Medicine
    University of Virginia School of MedicineClass of 1994

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 1998 - 2026
  • SC State Medical License
    SC State Medical License 2007 - 2009
  • GA State Medical License
    GA State Medical License 1995 - 1999
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Charlotte Magazine Top Doctors Charlotte Magazine, 2012-2013, 2017, 2020-2021, 2023-2024
  • Teal Acorn Innovator of the Year, Finalist Atrium Health, 2021
  • Pinnacle Award Finalist Atrium Health, 2020
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Disposition and bioavailability of ceftazidime after intraperitoneal administration in patients receiving continuous ambulatory peritoneal dialysis  
    T Bachelor, Journal of the American Society of Nephrology 7(11):2399-402 · November 1996, 11/1996

Press Mentions

  • Novo Holdings Co-Leads Hemab’s USD55m Series A
    Novo Holdings Co-Leads Hemab’s USD55m Series AJuly 22nd, 2021